Novo Nordisk stock jumps over 8% after rival Hims & Hers withdraws knockoff weight-loss drug amid regulatory scrutiny

Novo Nordisk stock jumps over 8% after rival Hims & Hers withdraws knockoff weight-loss drug amid regulatory scrutiny

Novo Nordisk stock jumps over 8% after rival Hims & Hers withdraws knockoff weight-loss drug amid regulatory scrutiny

Leave a Reply

Your email address will not be published. Required fields are marked *